Response of myasthenia gravis to rituxim
β
Ajeet Gajra; Neerja Vajpayee; Sara J. Grethlein
π
Article
π
2004
π
John Wiley and Sons
π
English
β 43 KB
π 2 views
## Abstract Myasthenia gravis is a Bβcellβmediated autoimmune neuromuscular disorder characterized by weakness and fatigability of skeletal muscles. The underlying defect is an autoantibodyβmediated attack on the acetylcholine receptors (AchRs) at the neuromuscular junction. Rituximab is a genetica